MD1003

biotin (high-dose) · MedDay Pharmaceuticals SA

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for MD1003, covering 2017-03-27 to 2020-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) [Phase 3]